A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.
Market Realist on MSN
How Colossal Biosciences uses CRISPR and the safeguards behind the science
Colossal Biosciences is establishing standards for how biotechnology can responsibly support biodiversity conservation in an ...
NIH-funded UT team and colleagues from Metagenomi Thereapeutics discovered highly efficient enzyme could enable targeted gene editing within the human body.
Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...
The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the ...
At the Healthcare Analytics Summit™ 2024 (HAS® 24), Jennifer Doudna, PhD, of the University of California, Berkeley, sat down with Melissa Welch, MD, MPH, President of Welch Perspectives Healthcare ...
In the first of a new series of GEN Keynote Webinars, Professor Rodolphe Barrangou, PhD (North Carolina State; EIC, The CRISPR Journal) offers a front-row perspective of the CRISPR revolution, the ...
NANJING, China, Dec. 7, 2023 /PRNewswire/ -- The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and ...
Breast cancer (BC) remains the most prevalent cancer among women worldwide, presenting significant challenges due to its high incidence and mortality rates. Traditional treatments, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results